CompoAtlas

Tricovel Tricoage45+ Tablets with Bioequolo

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Acide pantothénique

Source : D-Pantothénate de calcium

6 mg6,000 µg
Glycine max

Source : Graine(s)

100 mgNot calculated
Extrait d'isoflavone de soja

Source : Glycine max - Graine

13.4 Milligrammes d'équivalents aglycones d'isoflavonesNot calculated
Cuivre

Source : Diglycinate de cuivre (II)

1 mg1,000 µg
trans-Resvératrol

Source : Resvératrol

0.05 mgNot calculated
Biotine

Source : Biotine

0.05 mg50 µg

Non-medicinal ingredients

Stéarate de magnésium, Acide hyaluronique, Maltodextrine, Hydroxypropylméthylcellulose, Dioxyde de silicium, Cellulose microcristalline, Acide stéarique, Oxyde de fer jaune, Trioxyde de difer, Dioxyde de titane

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Tricovel TricoAge45+ Tablets with Bioequolo: Helps reduce hair shedding in women aged over 45 in menopause. Helps reduce shedding (-14.75%) in women aged over 45 in menopause. Helps maintain hair growth and hair follicle formation. Helps maintain maintain/support healthy hair. Helps improve/increase hair shaft diameter in women aged over 45 in menopause.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Giuliani S.p.A.
NPN or DIN-HM
80095164
Status
Active licence
Licence date
4 November 2019
Revision date
24 September 2025
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80095164

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycine max
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Tricovel Tricoage45+ Tablets with Bioequolo”, https://compoatlas.com/en/supplements/canada/80095164-tricovel-tricoage45-tablets-with-bioequolo, updated 24 September 2025.

Enter to analyse, Shift+Enter for a new line